Syndax Pharmaceuticals (SNDX) PT Lowered to $22 at Nomura/Instinet on Mixed 2Q Results
Tweet Send to a Friend
Nomura/Instinet lowered its price target on Syndax Pharmaceuticals (NASDAQ: SNDX) to $22.00 (from $27.00) while maintaining a Buy rating, following ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
